Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Tract Infections | 13 | 2021 | 780 | 1.670 |
Why?
|
Vesico-Ureteral Reflux | 10 | 2021 | 424 | 1.370 |
Why?
|
Urinary Bladder | 8 | 2021 | 1137 | 0.700 |
Why?
|
Urography | 2 | 2015 | 326 | 0.610 |
Why?
|
Dog Diseases | 1 | 2013 | 135 | 0.450 |
Why?
|
Autoantibodies | 4 | 2013 | 2008 | 0.420 |
Why?
|
Hydronephrosis | 4 | 2019 | 275 | 0.390 |
Why?
|
Cicatrix | 3 | 2020 | 691 | 0.380 |
Why?
|
Optic Nerve | 1 | 2013 | 553 | 0.370 |
Why?
|
Hypospadias | 2 | 2022 | 92 | 0.350 |
Why?
|
Bladder Exstrophy | 2 | 2020 | 92 | 0.300 |
Why?
|
Urologic Surgical Procedures | 4 | 2020 | 295 | 0.300 |
Why?
|
Radionuclide Imaging | 2 | 2021 | 2032 | 0.290 |
Why?
|
Protein Array Analysis | 4 | 2013 | 412 | 0.290 |
Why?
|
Mass Screening | 5 | 2020 | 5209 | 0.290 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 628 | 0.280 |
Why?
|
Replantation | 2 | 2016 | 149 | 0.280 |
Why?
|
Salmonella typhi | 3 | 2011 | 174 | 0.270 |
Why?
|
Urologic Diseases | 2 | 2019 | 252 | 0.260 |
Why?
|
Glaucoma | 1 | 2013 | 995 | 0.260 |
Why?
|
Ureter | 2 | 2016 | 363 | 0.250 |
Why?
|
Ureteroscopy | 3 | 2022 | 121 | 0.250 |
Why?
|
Lithotripsy, Laser | 1 | 2022 | 44 | 0.220 |
Why?
|
Orchiectomy | 2 | 2021 | 453 | 0.220 |
Why?
|
Circumcision, Male | 2 | 2020 | 151 | 0.210 |
Why?
|
Kidney | 5 | 2021 | 6881 | 0.210 |
Why?
|
Cryptorchidism | 1 | 2021 | 123 | 0.200 |
Why?
|
Dilatation, Pathologic | 2 | 2019 | 510 | 0.200 |
Why?
|
Spermatic Cord Torsion | 1 | 2020 | 75 | 0.190 |
Why?
|
Urologic Surgical Procedures, Male | 2 | 2017 | 90 | 0.190 |
Why?
|
Lasers, Solid-State | 1 | 2022 | 178 | 0.190 |
Why?
|
Child, Preschool | 23 | 2021 | 41198 | 0.190 |
Why?
|
Infant | 20 | 2021 | 34569 | 0.190 |
Why?
|
Typhoid Fever | 2 | 2011 | 164 | 0.190 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4561 | 0.180 |
Why?
|
Kidney Diseases | 2 | 2021 | 2124 | 0.180 |
Why?
|
Hernia, Inguinal | 1 | 2020 | 187 | 0.180 |
Why?
|
Urinary Tract | 2 | 2019 | 294 | 0.180 |
Why?
|
Keratin-5 | 1 | 2017 | 45 | 0.170 |
Why?
|
Urethral Stricture | 1 | 2017 | 58 | 0.160 |
Why?
|
Fluoroscopy | 2 | 2018 | 899 | 0.160 |
Why?
|
Nurse Practitioners | 1 | 2020 | 270 | 0.160 |
Why?
|
Retrospective Studies | 25 | 2022 | 72443 | 0.160 |
Why?
|
Child | 28 | 2022 | 74468 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 456 | 0.150 |
Why?
|
Hospitals, Pediatric | 4 | 2021 | 1776 | 0.150 |
Why?
|
Mood Disorders | 2 | 2013 | 1102 | 0.150 |
Why?
|
Ultrasonography | 7 | 2021 | 5922 | 0.150 |
Why?
|
Sperm Retrieval | 1 | 2015 | 18 | 0.150 |
Why?
|
Sacrococcygeal Region | 1 | 2016 | 53 | 0.150 |
Why?
|
Meningocele | 1 | 2016 | 43 | 0.140 |
Why?
|
Klinefelter Syndrome | 1 | 2015 | 46 | 0.140 |
Why?
|
Kidney Pelvis | 1 | 2016 | 180 | 0.140 |
Why?
|
Cystostomy | 1 | 2015 | 27 | 0.140 |
Why?
|
Male | 49 | 2022 | 350324 | 0.140 |
Why?
|
Bacteremia | 3 | 2011 | 969 | 0.140 |
Why?
|
Urothelium | 1 | 2017 | 282 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 767 | 0.140 |
Why?
|
Anti-Allergic Agents | 1 | 2016 | 143 | 0.130 |
Why?
|
Pharmaceutical Vehicles | 1 | 2014 | 61 | 0.130 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2016 | 161 | 0.130 |
Why?
|
Urinary Diversion | 1 | 2015 | 140 | 0.130 |
Why?
|
Epidemiology | 1 | 2017 | 295 | 0.130 |
Why?
|
Peanut Hypersensitivity | 1 | 2016 | 157 | 0.130 |
Why?
|
Appendix | 1 | 2015 | 113 | 0.130 |
Why?
|
Postoperative Complications | 6 | 2022 | 15079 | 0.130 |
Why?
|
Urology | 1 | 2018 | 369 | 0.120 |
Why?
|
Sucrose | 1 | 2014 | 186 | 0.120 |
Why?
|
Antigens, Bacterial | 2 | 2010 | 1190 | 0.120 |
Why?
|
Proteomics | 5 | 2021 | 3248 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2013 | 1171 | 0.120 |
Why?
|
Siblings | 2 | 2015 | 820 | 0.120 |
Why?
|
Spinal Dysraphism | 1 | 2015 | 152 | 0.120 |
Why?
|
Fever of Unknown Origin | 1 | 2013 | 93 | 0.120 |
Why?
|
Anaerobic Threshold | 1 | 2012 | 53 | 0.120 |
Why?
|
Costs and Cost Analysis | 2 | 2016 | 1669 | 0.120 |
Why?
|
Infant, Newborn | 10 | 2020 | 24798 | 0.120 |
Why?
|
Female | 45 | 2021 | 377204 | 0.120 |
Why?
|
RNA, Bacterial | 2 | 2011 | 395 | 0.120 |
Why?
|
Urination | 3 | 2021 | 203 | 0.110 |
Why?
|
Infertility, Male | 1 | 2015 | 407 | 0.110 |
Why?
|
Eosinophilic Esophagitis | 1 | 2014 | 144 | 0.110 |
Why?
|
Carbohydrates | 1 | 2014 | 355 | 0.110 |
Why?
|
Humans | 65 | 2022 | 715777 | 0.110 |
Why?
|
Cephalosporins | 1 | 2013 | 218 | 0.110 |
Why?
|
Data Mining | 1 | 2017 | 552 | 0.110 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 328 | 0.110 |
Why?
|
Prenatal Diagnosis | 1 | 2019 | 1179 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2015 | 323 | 0.110 |
Why?
|
Cholera | 2 | 2009 | 761 | 0.110 |
Why?
|
Lumbosacral Region | 1 | 2013 | 311 | 0.110 |
Why?
|
Diskectomy | 1 | 2013 | 194 | 0.110 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2014 | 642 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 1 | 2019 | 1600 | 0.110 |
Why?
|
Spondylolisthesis | 1 | 2013 | 161 | 0.110 |
Why?
|
Adolescent | 22 | 2021 | 85155 | 0.110 |
Why?
|
Desensitization, Immunologic | 1 | 2016 | 485 | 0.100 |
Why?
|
Urogenital Abnormalities | 1 | 2014 | 250 | 0.100 |
Why?
|
Salmonella paratyphi A | 1 | 2010 | 39 | 0.100 |
Why?
|
Paratyphoid Fever | 1 | 2010 | 32 | 0.100 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 2021 | 79 | 0.100 |
Why?
|
Bangladesh | 5 | 2011 | 799 | 0.100 |
Why?
|
Ultrasonography, Mammary | 1 | 2012 | 252 | 0.100 |
Why?
|
Recurrence | 5 | 2021 | 8240 | 0.100 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 717 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1761 | 0.090 |
Why?
|
Antibodies, Bacterial | 3 | 2010 | 1457 | 0.090 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2009 | 69 | 0.090 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 275 | 0.090 |
Why?
|
Helminthiasis | 1 | 2009 | 64 | 0.090 |
Why?
|
Neutropenia | 1 | 2013 | 876 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 987 | 0.090 |
Why?
|
Amino Acids | 1 | 2014 | 1711 | 0.090 |
Why?
|
Medical Records | 1 | 2014 | 1423 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2016 | 1380 | 0.080 |
Why?
|
Regeneration | 1 | 2017 | 1535 | 0.080 |
Why?
|
Blood | 1 | 2010 | 617 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 4046 | 0.080 |
Why?
|
Bacterial Proteins | 3 | 2011 | 3948 | 0.080 |
Why?
|
Herpes Zoster | 1 | 2010 | 288 | 0.080 |
Why?
|
Documentation | 1 | 2014 | 873 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2018 | 1771 | 0.080 |
Why?
|
Blotting, Western | 2 | 2013 | 5379 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2011 | 4040 | 0.080 |
Why?
|
Incidence | 5 | 2019 | 20731 | 0.080 |
Why?
|
Urine | 2 | 2020 | 381 | 0.080 |
Why?
|
Clostridium Infections | 1 | 2013 | 507 | 0.080 |
Why?
|
Health Resources | 1 | 2013 | 926 | 0.080 |
Why?
|
Young Adult | 14 | 2021 | 56226 | 0.080 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 371 | 0.080 |
Why?
|
Antigens, Neoplasm | 3 | 2011 | 1987 | 0.080 |
Why?
|
Colon | 1 | 2015 | 1759 | 0.080 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2009 | 407 | 0.080 |
Why?
|
Antipsychotic Agents | 2 | 2012 | 3062 | 0.070 |
Why?
|
Dietary Fats | 1 | 2014 | 2048 | 0.070 |
Why?
|
Gene Expression Profiling | 6 | 2014 | 9504 | 0.070 |
Why?
|
Metabolome | 1 | 2012 | 871 | 0.070 |
Why?
|
Verbal Learning | 1 | 2008 | 477 | 0.070 |
Why?
|
Risperidone | 1 | 2008 | 377 | 0.070 |
Why?
|
MicroRNAs | 2 | 2013 | 3637 | 0.070 |
Why?
|
Quality of Life | 2 | 2017 | 11721 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2017 | 3770 | 0.070 |
Why?
|
Vibrio cholerae | 2 | 2009 | 817 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2015 | 1923 | 0.070 |
Why?
|
Massachusetts | 2 | 2015 | 8743 | 0.070 |
Why?
|
Cost of Illness | 1 | 2015 | 1840 | 0.070 |
Why?
|
Hematologic Neoplasms | 2 | 2013 | 1688 | 0.070 |
Why?
|
Pseudomonas Infections | 1 | 2009 | 617 | 0.070 |
Why?
|
Poverty | 2 | 2013 | 2620 | 0.070 |
Why?
|
Thiazoles | 1 | 2012 | 1515 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 452 | 0.060 |
Why?
|
Spinal Fusion | 1 | 2013 | 1205 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2465 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1819 | 0.060 |
Why?
|
Psychotic Disorders | 2 | 2008 | 2847 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 2012 | 20062 | 0.060 |
Why?
|
Nicotine | 1 | 2008 | 641 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2009 | 753 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1562 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 1154 | 0.060 |
Why?
|
Holmium | 1 | 2022 | 30 | 0.060 |
Why?
|
Observer Variation | 2 | 2019 | 2676 | 0.060 |
Why?
|
Thulium | 1 | 2022 | 22 | 0.060 |
Why?
|
Depressive Disorder, Major | 2 | 2012 | 4454 | 0.060 |
Why?
|
Double-Blind Method | 5 | 2019 | 11945 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15199 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39300 | 0.060 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2015 | 2115 | 0.060 |
Why?
|
Orchiopexy | 1 | 2021 | 14 | 0.060 |
Why?
|
Adult | 21 | 2018 | 212266 | 0.050 |
Why?
|
Mental Recall | 1 | 2008 | 1192 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 2980 | 0.050 |
Why?
|
Health Status | 1 | 2015 | 4001 | 0.050 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 1269 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2490 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3681 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2524 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1133 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2985 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3846 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 7311 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2019 | 19537 | 0.050 |
Why?
|
Schizophrenic Psychology | 1 | 2008 | 1670 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7095 | 0.050 |
Why?
|
Radiopharmaceuticals | 2 | 2021 | 2757 | 0.050 |
Why?
|
Primary Health Care | 2 | 2013 | 4522 | 0.050 |
Why?
|
Cohort Studies | 6 | 2022 | 40029 | 0.050 |
Why?
|
Pelvic Pain | 1 | 2021 | 248 | 0.050 |
Why?
|
Penis | 1 | 2020 | 215 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3375 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 23438 | 0.040 |
Why?
|
Bipolar Disorder | 2 | 2013 | 5054 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14902 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 2077 | 0.040 |
Why?
|
Attention | 1 | 2008 | 2386 | 0.040 |
Why?
|
Postnatal Care | 1 | 2019 | 230 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 23464 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 415 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8045 | 0.040 |
Why?
|
Leukocytes | 1 | 2005 | 2092 | 0.040 |
Why?
|
Sex Factors | 3 | 2019 | 10666 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12535 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2020 | 4905 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 572 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4893 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 9004 | 0.040 |
Why?
|
Cell Tracking | 1 | 2017 | 147 | 0.040 |
Why?
|
Immunoglobulin A | 2 | 2010 | 969 | 0.040 |
Why?
|
Syndrome | 1 | 2021 | 3193 | 0.030 |
Why?
|
Microarray Analysis | 2 | 2010 | 778 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2020 | 62004 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8075 | 0.030 |
Why?
|
United States | 6 | 2020 | 67905 | 0.030 |
Why?
|
Time Factors | 4 | 2020 | 40875 | 0.030 |
Why?
|
Skin Tests | 1 | 2016 | 646 | 0.030 |
Why?
|
Reoperation | 2 | 2015 | 4169 | 0.030 |
Why?
|
Middle Aged | 13 | 2015 | 214639 | 0.030 |
Why?
|
Lung | 1 | 2013 | 9735 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 885 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2014 | 289 | 0.030 |
Why?
|
Budesonide | 1 | 2014 | 154 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1586 | 0.030 |
Why?
|
Peptides | 2 | 2020 | 4384 | 0.030 |
Why?
|
Chile | 1 | 2013 | 227 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2415 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2014 | 325 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2018 | 900 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12248 | 0.030 |
Why?
|
Palpation | 1 | 2012 | 172 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2014 | 398 | 0.030 |
Why?
|
Odds Ratio | 2 | 2015 | 9984 | 0.030 |
Why?
|
General Practitioners | 1 | 2013 | 104 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7954 | 0.030 |
Why?
|
Animals | 6 | 2017 | 169420 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2013 | 13213 | 0.030 |
Why?
|
Pregnancy | 3 | 2019 | 27398 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 948 | 0.030 |
Why?
|
Organogenesis | 1 | 2013 | 235 | 0.030 |
Why?
|
Neuralgia, Postherpetic | 1 | 2010 | 46 | 0.020 |
Why?
|
Metaplasia | 1 | 2011 | 311 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 461 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1187 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2743 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18784 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1496 | 0.020 |
Why?
|
Cell Count | 1 | 2014 | 1912 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2013 | 836 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1715 | 0.020 |
Why?
|
Lipopolysaccharides | 2 | 2009 | 2244 | 0.020 |
Why?
|
Eosinophils | 1 | 2014 | 935 | 0.020 |
Why?
|
Schizophrenia | 1 | 2008 | 6702 | 0.020 |
Why?
|
Vidarabine | 1 | 2010 | 348 | 0.020 |
Why?
|
Herpesvirus 3, Human | 1 | 2010 | 219 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 34430 | 0.020 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2010 | 192 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2010 | 564 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 5050 | 0.020 |
Why?
|
Neprilysin | 1 | 2011 | 420 | 0.020 |
Why?
|
Allergens | 1 | 2016 | 1296 | 0.020 |
Why?
|
Infertility | 1 | 2015 | 580 | 0.020 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 85 | 0.020 |
Why?
|
Virus Activation | 1 | 2010 | 329 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2594 | 0.020 |
Why?
|
Risk Factors | 4 | 2015 | 70866 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4492 | 0.020 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2008 | 88 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6105 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2017 | 1829 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2928 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 2086 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 419 | 0.020 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2008 | 266 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 562 | 0.020 |
Why?
|
Epithelium | 1 | 2011 | 1721 | 0.020 |
Why?
|
Cholera Toxin | 1 | 2009 | 553 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9030 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5064 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2008 | 704 | 0.020 |
Why?
|
Inflammation | 1 | 2005 | 10081 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10435 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2137 | 0.020 |
Why?
|
Virulence | 1 | 2009 | 1338 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2010 | 1528 | 0.020 |
Why?
|
Mice | 4 | 2017 | 80375 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1659 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 21797 | 0.020 |
Why?
|
Vitamin A | 1 | 2008 | 630 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2599 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2198 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1785 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9377 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2008 | 964 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12456 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 1602 | 0.020 |
Why?
|
Cell Survival | 1 | 2014 | 6035 | 0.020 |
Why?
|
Th1 Cells | 1 | 2009 | 1074 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 6978 | 0.020 |
Why?
|
Zinc | 1 | 2008 | 689 | 0.020 |
Why?
|
Th2 Cells | 1 | 2009 | 1053 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 2008 | 421 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2973 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2008 | 2015 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3524 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2222 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2013 | 2550 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2371 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1104 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2729 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5265 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7757 | 0.010 |
Why?
|
Arousal | 1 | 2008 | 1140 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4824 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2942 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5397 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12480 | 0.010 |
Why?
|
Acute Disease | 1 | 2012 | 7140 | 0.010 |
Why?
|
Reaction Time | 1 | 2008 | 2111 | 0.010 |
Why?
|
Hospitals | 1 | 2014 | 3375 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1984 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 14911 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7895 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6495 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3947 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 51315 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11655 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 5031 | 0.010 |
Why?
|
Aged | 4 | 2013 | 162448 | 0.010 |
Why?
|
Spleen | 1 | 2005 | 2463 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2011 | 3638 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 2804 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6722 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2010 | 2802 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10620 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19910 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11145 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2947 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4194 | 0.010 |
Why?
|
Exercise | 1 | 2012 | 5427 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2613 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2008 | 3741 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 6873 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 12919 | 0.010 |
Why?
|
Depression | 1 | 2013 | 7268 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16311 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13618 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9809 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29005 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 4751 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 11940 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 22665 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58323 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17409 | 0.000 |
Why?
|
Mutation | 1 | 2009 | 29291 | 0.000 |
Why?
|